Harmony Biosciences
HRMY
₹2,739
Share price
-0.25%
Change (1 day)
9.03%
Change (1 year)
Categories
Harmony Biosciences (HRMY) - Cash on Hand
Cash on Hand as of March 2025 : ₹43.59 Billion
According to Harmony Biosciences's latest financial reports the company has ₹43.59 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Harmony Biosciences - Cash on Hand chart (from 2019 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | ₹40.07 B | 1351.83% |
| 2023-12-31 | ₹2.76 B | 9.35% |
| 2022-12-31 | ₹2.52 B | -85.52% |
| 2021-12-31 | ₹17.43 B | 4.3% |
| 2020-12-31 | ₹16.72 B | 858.73% |
| 2019-12-31 | ₹1.74 B | -70.14% |
| 2018-12-31 | ₹5.84 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | ₹1.40 B | -96.77% | 🇺🇸 USA |
 OPKO Health
OPK | ₹37.49 B | -14.00% | 🇺🇸 USA |